US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% SDEV $7.48 ▲+0.00% AMD $633.91 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Articles published by Arcus Biosciences, Inc.

News headline image
Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration
From Arcus Biosciences, Inc.
Via Business Wire
Tickers GILD RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
From Arcus Biosciences, Inc.
Via Business Wire
Tickers RCUS